CIK 0001724521
- Large accelerated filer
Arcus Biosciences, Inc.
Sign in to watch- Ticker
- RCUS
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 473898435
- Phone
- +1 510-694-6200
- Business address
- 3928 POINT EDEN WAY, HAYWARD, CA, 94545
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $84,810
- in 1 filing, $85K under 10b5-1 plans
Net −$84,810. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-23 | ROSEN TERRY J Chief Executive Officer | Grant or award | +79,000 | 2,236,409 | ||
| 2026-01-23 | ROSEN TERRY J Chief Executive Officer | Grant or award · Stock Option (right to buy) | +315,000 | 315,000 | ||
| 2026-01-08 | ROSEN TERRY J Chief Executive Officer | Gift | −35,000 | 2,157,409 | ||
| 2025-12-30 | ROSEN TERRY J Chief Executive Officer | Gift | −2,400 | 2,192,409 | ||
| 2025-12-17 | ROSEN TERRY J Chief Executive Officer | Sale 10b5-1 | −25,744 | $22.16 | $570K | 2,194,809 |
| 2025-12-16 | ROSEN TERRY J Chief Executive Officer | Sale 10b5-1 | −28,947 | $21.88 | $633K | 2,220,553 |
| 2025-02-27 | ROSEN TERRY J Chief Executive Officer | Purchase | +19,800 | $10.18 | $201K | 2,554,160 |
| 2025-01-23 | ROSEN TERRY J Chief Executive Officer | Grant or award | +165,000 | 2,534,360 | ||
| 2025-01-23 | ROSEN TERRY J Chief Executive Officer | Grant or award · Stock Option (right to buy) | +650,000 | 650,000 | ||
| 2024-12-15 | ROSEN TERRY J Chief Executive Officer | Shares withheld for taxes | −37,882 | $16.08 | $609K | 2,369,360 |
| 2024-06-15 | ROSEN TERRY J Chief Executive Officer | Shares withheld for taxes | −12,670 | $16.97 | $215K | 3,954,304 |
| 2024-01-23 | ROSEN TERRY J Chief Executive Officer | Grant or award | +100,000 | 3,966,974 | ||
| 2024-01-23 | ROSEN TERRY J Chief Executive Officer | Grant or award · Stock Option (right to buy) | +405,900 | 405,900 | ||
| 2023-12-29 | ROSEN TERRY J Chief Executive Officer | Other acquisition | +448 | 3,866,974 | ||
| 2023-12-19 | ROSEN TERRY J Chief Executive Officer | Returned to the company 10b5-1 | −14,000 | $18.09 | $253K | 3,866,526 |
| 2023-12-18 | ROSEN TERRY J Chief Executive Officer | Returned to the company 10b5-1 | −13,705 | $17.74 | $243K | 3,880,526 |
| 2023-06-16 | ROSEN TERRY J Chief Executive Officer | Returned to the company 10b5-1 | −8,762 | $19.35 | $170K | 3,894,231 |
| 2023-01-23 | ROSEN TERRY J Chief Executive Officer | Grant or award | +105,700 | 469,123 | ||
| 2023-01-23 | ROSEN TERRY J Chief Executive Officer | Grant or award · Stock Option (right to buy) | +429,000 | 429,000 | ||
| 2022-12-16 | ROSEN TERRY J Chief Executive Officer | Sale | −10,983 | $30.66 | $337K | 244,233 |
Page 1 of 2 · 39 trades